TGF-{beta} potentiates airway smooth muscle responsiveness to bradykinin
1 Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine; 2 The Wistar Institute, Philadelphia, Pennsylvania; and 3 Ludwig Institute for Cancer Research, New York, New York Submitted 18 January 2005 ; accepted in final form 18 May 2005 T...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Lung cellular and molecular physiology 2005-10, Vol.289 (4), p.L511 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1 Pulmonary, Allergy, and Critical Care Division, Department of Medicine, University of Pennsylvania School of Medicine; 2 The Wistar Institute, Philadelphia, Pennsylvania; and 3 Ludwig Institute for Cancer Research, New York, New York
Submitted 18 January 2005
; accepted in final form 18 May 2005
The molecular mechanisms by which bradykinin induces excessive airway obstruction in asthmatics remain unknown. Transforming growth factor (TGF)- has been involved in regulating airway inflammation and remodeling in asthma, although it is unknown whether TGF- can modulate bradykinin-associated bronchial hyperresponsiveness. To test whether TGF- directly modulates airway smooth muscle (ASM) responsiveness to bradykinin, isolated murine tracheal rings were used to assess whether TGF- alters ASM contractile responsiveness to bradykinin. Interestingly, we found TGF- -treated murine rings (12.5 ng/ml, 18 h) exhibited increased expression of bradykinin 2 (B 2 ) receptors and became hyperreactive to bradykinin, as shown by increases in maximal contractile responses and receptor distribution. We investigated the effect of TGF- on bradykinin-evoked calcium signals since calcium is a key molecule regulating ASM excitation-contraction coupling. We reported that TGF- , in a dose- (0.510 ng/ml) and time- (224 h) dependent manner, increased mRNA and protein expression of the B 2 receptor in cultured human ASM cells. Maximal B 2 receptor protein expression that colocalized with CD44, a marker of membrane cell surface, occurred after 18 h of TGF- treatment and was further confirmed using fluorescence microscopy. TGF- (2.5 ng/ml, 18 h) also increased bradykinin-induced intracellular calcium mobilization in fura-2-loaded ASM cells. TGF- -mediated enhancement of calcium mobilization was not attenuated with indomethacin, a cyclooxygenase inhibitor. These data demonstrate for the first time that TGF- may play a role in mediating airway hyperresponsiveness to bradykinin seen in asthmatics by enhancing ASM contractile responsiveness to bradykinin, possibly as a result of increased B 2 receptor expression and signaling.
airway hyperresponsiveness; airway remodeling; intracellular calcium; isometric force generation; transforming growth factor-
Address for reprint requests and other correspondence: Y. Amrani, 3615 Civic Center Blvd., Lab 1016J-Abramson Research Center, Pulmonary, Allergy, and Critical Care Division, Dept. of Medicine, Univ. of Pennsylvania School of Medicine, Philadelp |
---|---|
ISSN: | 1040-0605 1522-1504 |
DOI: | 10.1152/ajplung.00027.2005 |